BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 920363)

  • 1. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
    McDonald JW; Stuart RK; Barnett HJ
    Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J
    JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract]   [Full Text] [Related]  

  • 4. A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway.
    Pay GF; Wallis RB; Zelaschi D
    Biochem Soc Trans; 1980 Dec; 8(6):727-8. PubMed ID: 7461266
    [No Abstract]   [Full Text] [Related]  

  • 5. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs.
    Ali M; McDonald JW
    Thromb Res; 1978 Dec; 13(6):1057-65. PubMed ID: 571150
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.
    Townsend ER; Duffin J; Ali M; McDonald JW; Thiesson JJ; Masterson J; Klement P; Cooper JD
    Circ Res; 1981 Aug; 49(2):452-7. PubMed ID: 7249281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
    Lagarde M; Dechavanne M
    Lancet; 1977 Jan; 1(8002):88. PubMed ID: 63724
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of platelets in transient ischemic attacks and cerebral vascular accidents.
    Barnett HJ
    Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
    Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
    Steele P; Carroll J; Overfield D; Genton E
    Stroke; 1977; 8(3):396-8. PubMed ID: 871029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acetylsalicylic acid, sulfinpyrazone and their combination on collagen-induced platelet aggregation in guinea pigs.
    Wong LT; Zawidzka Z; Thomas BH
    Pharmacol Res Commun; 1978 Nov; 10(10):939-49. PubMed ID: 733865
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of antilymphocyte globulin on platelets.
    Rosenberg JC; Lekas N; Lysz K; Morrell R; Sell T; Villalalva A
    Proc Clin Dial Transplant Forum; 1974; (4):119-23. PubMed ID: 4468409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.